AST Clinical Investigation
Overview
Blood glucose monitoring system are tested in the alternative site to validate the accuracy of the blood glucose.
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Diagnostic
- Masking: None (Open Label)
- Study Primary Completion Date: December 2010
Interventions
- Device: blood glucose monitor
- Blood glucose monitor is used to monitor the blood glucose level of the human-being
- Device: blood glucose monitor
- Blood glucose monitor is used to monitor the blood glucose level of the human-being.
Arms, Groups and Cohorts
- Experimental: Andon
- Andon blood glucose test strips with test meter
- Active Comparator: Lifescan
Clinical Trial Outcome Measures
Primary Measures
- blood glucose value
- Time Frame: 5 seconds
Participating in This Clinical Trial
Inclusion Criteria
- people ( disbetes people)with at least 8 hours of limosis Exclusion Criteria:
- After meal(when doing the test) – take Hypoglycemic Drugs(when doing the test) – with insulin(when doing the test) – after strenuous exercise(when doing the test) – Pregnant women – neonates – patients in a hyperglycemic-hyperosmolur state, with or without ketosis. – patients who are dehydrated, hypertensive, hypotensive or in shock.
Gender Eligibility: All
Minimum Age: 21 Years
Maximum Age: 78 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Andon Medical Co.,Ltd
- Provider of Information About this Clinical Study
- Yi Liu, Andon Medical Co.,Ltd
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.